Some patients fear injections so much that they avoid getting proper medical treatment, sometimes with life-threatening results. Transdermal patches, which administer drugs through the skin, could make the bite of the needle a mere unpleasant memory.
The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. Pfizer and GlaxoSmithKline are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.
Embryonic stem-cell research would get a financial boost under a new proposal by the National Institutes of Health. According to the Wall Street Journal, the NIH guidelines expand funding for cell lines derived from surplus human embryos.
According to the National Kidney Foundation, over 26 million Americans suffer from chronic kidney disease (CKD), a progressive condition in which the kidneys allow waste to build up in the blood.
President Obama’s recent reversal of Bush’s policy on embryonic stem cell research reignited the debate over the ethical limits of science. However, as the Wall Street Journal reports, an innovative new technique could potentially reproduce the benefits of embryonic stem cells without the attendant controversy.
Foundation Radiology Group, a provider of diagnostic imaging services to hospitals and medical institutions, announced that it has raised $10 million in the company’s first round of venture funding.
While prosthetic legs have undergone remarkable advances in the past decades, the typical prosthetic arm hasn’t changed much since World War II: an artificial limb with a hook on the end. It’s a less than thrilling prospect for U.S. soldiers returning from Iraq or Afghanistan with amputated arms.
The economic climate may be grim, but biotech banker G. Steven Burrill is looking to the future. The CEO of Burrill and Co. plans to invest $1 billion into Minnesota’s Pine Island biotechnology project and a private equity/venture capital fund.
Big news at ORTHOCON, DeviceSpace reports. The New Jersey-based company, which develops devices that deliver therapeutics to bone, recently announced the appointment of a new CEO and the closing of $25 million in Series B funding.
As Baby Boomers age, the market for arthroplasty, or joint replacement, is expected to grow rapidly in the coming years. Disc Motion Technologies (DMT) of Boca Raton, FL, has pioneered the first total joint replacement technique for the lumbar spine.
Copyright © 2026 | WordPress Theme by MH Themes